Latest Insider Transactions at Biodesix Inc (BDSX)
This section provides a real-time view of insider transactions for Biodesix Inc (BDSX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIODESIX INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIODESIX INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 30
2023
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
11,849
+0.06%
|
$11,849
$1.36 P/Share
|
May 25
2023
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
52,508
+0.25%
|
$52,508
$1.36 P/Share
|
May 24
2023
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
35,308
+0.17%
|
$35,308
$1.25 P/Share
|
May 23
2023
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
56,782
+0.28%
|
$56,782
$1.15 P/Share
|
May 22
2023
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
29,425
+0.14%
|
$29,425
$1.11 P/Share
|
May 10
2023
|
Gary Anthony Pestano Chief Development Officer |
SELL
Open market or private sale
|
Direct |
426
-0.43%
|
$426
$1.58 P/Share
|
May 10
2023
|
Scott Hutton President & CEO |
SELL
Open market or private sale
|
Direct |
3,848
-1.57%
|
$3,848
$1.58 P/Share
|
May 10
2023
|
Ryan H Siurek Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
564
-1.38%
|
$564
$1.58 P/Share
|
May 10
2023
|
Kieran O'Kane Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
474
-1.27%
|
$474
$1.58 P/Share
|
May 10
2023
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
SELL
Open market or private sale
|
Direct |
973
-0.82%
|
$973
$1.58 P/Share
|
May 09
2023
|
Gary Anthony Pestano Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,101
-1.09%
|
$1,101
$1.57 P/Share
|
May 09
2023
|
Scott Hutton President & CEO |
SELL
Open market or private sale
|
Direct |
9,934
-3.9%
|
$9,934
$1.57 P/Share
|
May 09
2023
|
Ryan H Siurek Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,456
-3.44%
|
$1,456
$1.57 P/Share
|
May 09
2023
|
Kieran O'Kane Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,223
-3.18%
|
$1,223
$1.57 P/Share
|
May 09
2023
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
SELL
Open market or private sale
|
Direct |
2,512
-2.08%
|
$2,512
$1.57 P/Share
|
May 08
2023
|
Gary Anthony Pestano Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,054
+4.77%
|
-
|
May 08
2023
|
Scott Hutton President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,778
+14.96%
|
-
|
May 08
2023
|
Ryan H Siurek Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,484
+11.48%
|
-
|
May 08
2023
|
Kieran O'Kane Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,461
+12.44%
|
-
|
May 08
2023
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,575
+8.74%
|
-
|
Mar 31
2023
|
Jon Faiz Kayyem |
BUY
Exercise of conversion of derivative security
|
Direct |
145,833
+45.11%
|
-
|
Mar 31
2023
|
Hany Massarany |
BUY
Exercise of conversion of derivative security
|
Direct |
145,833
+33.95%
|
-
|
Mar 31
2023
|
Charles M Watts |
BUY
Exercise of conversion of derivative security
|
Direct |
150,711
+42.72%
|
-
|
Feb 09
2023
|
Kieran O'Kane Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,999
-8.0%
|
$1,999
$1.8 P/Share
|
Feb 09
2023
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
SELL
Open market or private sale
|
Direct |
4,220
-4.08%
|
$4,220
$1.8 P/Share
|
Feb 09
2023
|
Ryan H Siurek Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,016
-6.91%
|
$2,016
$1.8 P/Share
|
Feb 09
2023
|
Scott Hutton President & CEO |
SELL
Open market or private sale
|
Direct |
16,278
-7.54%
|
$16,278
$1.8 P/Share
|
Feb 09
2023
|
Gary Anthony Pestano Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,852
-1.89%
|
$1,852
$1.8 P/Share
|
Feb 08
2023
|
Kieran O'Kane Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,461
+17.93%
|
-
|
Feb 08
2023
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,575
+10.06%
|
-
|
Feb 08
2023
|
Ryan H Siurek Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,483
+15.82%
|
-
|
Feb 08
2023
|
Scott Hutton President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,777
+17.17%
|
-
|
Feb 08
2023
|
Gary Anthony Pestano Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,053
+4.91%
|
-
|
Jan 31
2023
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.05%
|
$20,000
$2.41 P/Share
|
Jan 27
2023
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
50,000
+0.24%
|
$100,000
$2.51 P/Share
|
Dec 21
2022
|
Jon Faiz Kayyem |
BUY
Exercise of conversion of derivative security
|
Direct |
31,619
+50.0%
|
-
|
Dec 16
2022
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.05%
|
$10,000
$1.7 P/Share
|
Dec 15
2022
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
20,000
+0.1%
|
$20,000
$1.65 P/Share
|
Dec 14
2022
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
189,675
+0.93%
|
$189,675
$1.65 P/Share
|
Dec 13
2022
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
67,402
+0.33%
|
$67,402
$1.58 P/Share
|
Dec 12
2022
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.5%
|
$100,000
$1.48 P/Share
|
Nov 21
2022
|
Lawrence T. Kennedy Jr |
BUY
Open market or private purchase
|
Indirect |
10,869,565
+42.45%
|
$10,869,565
$1.15 P/Share
|
Nov 21
2022
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
17,391
+15.91%
|
$17,391
$1.15 P/Share
|
Nov 21
2022
|
Robert William Georgantas Iii Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+23.95%
|
$12,000
$1.15 P/Share
|
Nov 21
2022
|
Jon Faiz Kayyem |
BUY
Open market or private purchase
|
Indirect |
173,913
+50.0%
|
$173,913
$1.15 P/Share
|
Nov 21
2022
|
Matthew Strobeck |
BUY
Open market or private purchase
|
Indirect |
1,799,997
+47.16%
|
$1,799,997
$1.15 P/Share
|
Nov 21
2022
|
Matthew Strobeck |
BUY
Open market or private purchase
|
Direct |
869,565
+26.47%
|
$869,565
$1.15 P/Share
|
Nov 21
2022
|
Kieran O'Kane Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,347
+18.21%
|
$4,347
$1.15 P/Share
|
Nov 21
2022
|
Scott Hutton President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
65,217
+27.58%
|
$65,217
$1.15 P/Share
|
Nov 21
2022
|
Ryan H Siurek Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,695
+26.85%
|
$8,695
$1.15 P/Share
|